Clinical variability of bacterial vaginosis and trichomoniasis

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 49, Issue 10, 2004, Pages 781-786

  Brown Jr , Dale ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Bacterial vaginosis; Trichomonas vaginitis; Vaginal diseases

Indexed keywords

CLINDAMYCIN; METRONIDAZOLE; PHENOBARBITAL; PHENYTOIN;

ANAPHYLAXIS; CHLAMYDIA; CLINICAL FEATURE; CONFERENCE PAPER; DRUG ERUPTION; DRUG HYPERSENSITIVITY; ENDOMETRITIS; HIGH RISK PREGNANCY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LACTOBACILLUS; PH MEASUREMENT; PREGNANCY; PREGNANCY COMPLICATION; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PRIORITY JOURNAL; RISK ASSESSMENT; SCREENING; SEXUAL BEHAVIOR; SEXUALITY; SEXUALLY TRANSMITTED DISEASE; TRICHOMONAS VAGINALIS; TRICHOMONIASIS; URTICARIA; VAGINITIS; VIRUS TRANSFORMATION;

ADULT; AGE DISTRIBUTION; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TRICHOMONAS INFECTIONS; VAGINOSIS, BACTERIAL;

EID: 7244228214     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (20)

1. Cauci S, Gauaschino S, Driussi S, et al: Correlation of local interleukin-8 with immunoglobulin A against Gardnerella vaginalis hemolysin and with prolidase and sialidase levels in women with bacterial vaginosis. J Infect Dis 2002;185:1614-1620
2. Simpson T: Pediatricians in primary care and adolescent health care: Their practices and perceived CME needs. Poster presentation, Society for Adolescent Medicine, Seattle, March 20, 2003
3. Amsel R, Totten PA, Spiegel CA, et al: Nonspecific vaginitis: Diagnostic criteria and microbial and epidemiologic associations. Am J Med 1983;74:14-22
4. Sturm-Ramirez K, Gaye-Diallo A, Eisean G, et al: High levels of tumor necrosis factor-alpha and interleukin-1B in bacterial vaginosis may increase susceptibility to human immunodeficiency virus. J Infect Dis 2000;182:467-473
5. Hillier SL, Kiviat NB, Hawes SE, et al: Role of bacterial vaginosis-associated microorganisms in endometritis. Am J Obstet Gynecol 1996;175:435-441
6. Larsson PG, Platz-Christensen JJ, Thejls H, et al: Incidence of pelvic inflammatory disease after first-trimester legal abortion in women with bacterial vaginosis after treatment with metronidazole: A double-blind randomized study. Am J Obstet Gynecol 1992;166:100-103
7. Hillier SL, Nugent RP, Eschenbach DA, et al: Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant: The Vaginal Infections and Prematurity Study Group. N Engl J Med 1995;333:1737-1742
8. McGregor JA, French JI, Parker R, et al: Vaginal fluid enzymes in pregnancy: Correlation with cervico-vaginal infections. Presented at 1993 Annual Scientific Meeting and Symposium of the Infectious Disease Society for Obstetrics and Gynecology, Stout, Vermont, August 4-7, 1993
9. Carey JC, Klebanoff MA, Hauth JC, et al: Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis: National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 2000;342:534-540
10. Centers for Disease Control and Prevention: 1998 Guidelines for treatment of sexually transmitted diseases. MMWR Morbid Mortal Wkly Rep 1997;47:no RR-1
11. Einarson A, Koren G: Bacterial vaginosis during pregnancy: Should we screen for and treat it? Can Fam Physician 2002;48:877-878
12. Larsson PG, Platz-Christensen JJ, Forsum U, et al: Clue cells in predicting infections after abdominal hysterectomy. Obstet Gynecol 1991;77:450-452
13. Persson E, Bergstrom M, Larsson PG, et al: Infections after hysterectomy: A prospective nation-wide Swedish study: The Study Group on Infectious Diseases in Obstetrics and Gynecology within the Swedish Society of Obstetrics and Gynecology. Acta Obstet Gynecol Scand 1996;75:757-761
14. Cu-Uvin S, Hogan JW, Caliendo AM, et al: Association between bacterial vaginosis and expression of human immunodeficiency virus type 1 RNA in the female genital tract. Clin Infect Dis 2001;33:894-896
15. Antonio MA, Hawes SE, Hillier SL: The identification of vaginal Lactobacillus species and the demographic and microbiologic characteristics of women colonized by these species. J Infect Dis 1999;180:1950-1956
16. Wendel KA, Rompalo AM, Erbelding EJ, et al: Double-stranded RNA viral infection of Trichomonas vaginalis infecting patients attending a sexually transmitted diseases clinic. J Infect Dis 2002;186:558-561
17. Cochrane Database Syst Rev 2002;3:CD 000220
18. Diclemente RJ, Wingood GM, Sionean C, et al: Association of adolescents' history of sexually transmitted disease (STD) and their current high-risk behavior and STD status: A case for intensifying clinic-based prevention efforts. Sex Transm Dis 2002;29:503-509
19. Crossnoe CR, Germanas JP, LeMagueres P, et al: The crystal structure of Trichomonas vaginalis ferredoxin provides insight into metronidazole activation. J Mol Biol 2002;318:503-518
20. Pearlman MD, Yashar C, Ernst S, et al: An incremental dosing protocol for women with severe vaginal trichomoniasis and adverse reaction to metronidazole. Am J Obstet Gynecol 1996;174:934-936